Synovics Pharmaceuticals, Inc. SYVC
0.00 USD 0.00 (+0.00%)
At close·Nov 2, 2026, 4:00 PM EST
0.0001 52-week range 0.0001
- YTD
- 0.00%
- 1 year
- 0.00%
Altman Z-Score
-6.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -2.1×
P/S 0.3×
P/B 1.6×
P/FCF 2.6×
EV/EBITDA -7.9×
EV/Sales 0.6×
FCF Yield 38.3%
Gross Margin 34.6%
Operating Margin -9.6%
Net Margin -15.4%
ROE -80.1%
ROIC -21.5%
ROA -17.9%
Revenue 10.6%
Operating Income 75.8%
EPS (diluted) 84.4%
Free Cash Flow 171.8%
Current Ratio 0.5×
Quick Ratio 0.3×
Debt / Equity 1.3×
Net Debt / EBITDA -3.5×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2008-10-31